» Articles » PMID: 32857603

Teleoncology or Telemedicine for Oncology Patients During the COVID-19 Pandemic: the New Normal for Breast Cancer Survivors?

Overview
Journal Future Oncol
Specialty Oncology
Date 2020 Aug 29
PMID 32857603
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Telemedicine is seen as a savior during the COVID-19 pandemic. This study is a descriptive cross-sectional study conducted with cancer patients who were interviewed via telemedicine from a tertiary care comprehensive oncology center. A total of 421 patients were included in the study and 118 of them (28.0%) were >65 years old. Communication was provided most frequently by voice call (n = 213; 50.5%). The majority of the patients contacted by telemedicine had breast cancer (n = 270; 64.1%). For 135 patients (32.1%) no further examination or intervention was required and the previously planned follow-up visit was postponed by the clinician. This study showed that telemedicine could open a new era for medical oncology specialists.

Citing Articles

Effect of the COVID-19 Pandemic on the Management of Breast Cancer Patients.

Dalda Y, Akbulut S, Kucukakcali Z, Ogut Z, Dalda O, Alan S J Clin Med. 2025; 13(24.

PMID: 39768596 PMC: 11678252. DOI: 10.3390/jcm13247673.


Telehealth in breast cancer following the coronavirus disease 2019 pandemic.

Zeghondy J, Rassy E, Lapidari P, Eid R, Pistilli B Explor Target Antitumor Ther. 2024; 4(6):1249-1259.

PMID: 38213534 PMC: 10776597. DOI: 10.37349/etat.2023.00195.


The COVID-19 pandemic and its effects on follow-up of patients with early breast cancer: A patient survey.

Beltran-Bless A, Larocque G, Brackstone M, Arnaout A, Caudrelier J, Boone D Breast Cancer Res Treat. 2024; 204(3):531-538.

PMID: 38194133 DOI: 10.1007/s10549-023-07232-3.


Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals.

Bisceglia I, Canale M, Silvestris N, Gallucci G, Camerini A, Inno A Front Cardiovasc Med. 2023; 10:1223660.

PMID: 37786510 PMC: 10541962. DOI: 10.3389/fcvm.2023.1223660.


Clinical outcomes in patients with solid tumors living in rural and urban areas followed via telemedicine: experience in a highly complex latin american hospital.

Restrepo J, Alarcon J, Hernandez A, Sangiovanni S, Gonzalez S, Gallego K BMC Cancer. 2023; 23(1):253.

PMID: 36927771 PMC: 10018944. DOI: 10.1186/s12885-023-10717-5.


References
1.
Kang J, Wong R, Sherman E, Rybkin A, McBride S, Riaz N . The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer. Cancer. 2020; 126(18):4092-4104. PMC: 7361524. DOI: 10.1002/cncr.33031. View

2.
Hau Y, Kim J, Hur J, Chang M . How about actively using telemedicine during the COVID-19 pandemic?. J Med Syst. 2020; 44(6):108. PMC: 7190457. DOI: 10.1007/s10916-020-01580-z. View

3.
Doarn C, Merrell R . The Day the Earth Stood Still: COVID-19. Telemed J E Health. 2020; 26(5):569-570. DOI: 10.1089/tmj.2020.29039.crd. View

4.
Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R . Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020; 31(7):894-901. PMC: 7270947. DOI: 10.1016/j.annonc.2020.03.296. View

5.
Gill S, Hao D, Hirte H, Campbell A, Colwell B . Impact of COVID-19 on Canadian medical oncologists and cancer care: Canadian Association of Medical Oncologists survey report. Curr Oncol. 2020; 27(2):71-74. PMC: 7253737. DOI: 10.3747/co.27.6643. View